Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2026-01-05 @ 6:03 PM
Study NCT ID:
NCT00950768
Status:
COMPLETED
Last Update Posted:
2009-08-03
First Post:
2009-07-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients
Sponsor:
Azienda Ospedaliera San Giovanni Battista
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GISMM2001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Mario Boccadoro
Old Organization:
Division of Hematology - University of Torino - A.O.U. San Giovanni Battista